InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,017.30
(
-1.07%
)
US TECH 100
16,800.40
(
-1.52%
)
Dow Jones
37,903.22
(
-1.45%
)
Brent Oil
86.86
(
-0.42%
)
Bitcoin
64,097.44
(
-0.29%
)
Post# of 3956
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whytestocks

Send PM Follow Ignore
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

whytestocks

Re: None

Friday, 04/12/2019 8:10:36 AM

Friday, April 12, 2019 8:10:36 AM

Post# of 3956
News: $KLDO Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress(TM) 2019 (EASL)

LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today presen...

In case you are interested https://marketwirenews.com/news-releases/kaleido-biosciences-announces-presentation-of-clinical-study-and-ex-vivo-data-supporting-the-development-of-novel-microbiome-metabolic-therapies-for-hyperammonemia-at-the-international-liver-congress-tm-2019-easl--7990462.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up